Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony L Gotter

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Neuroreport|September 5, 2006
A Timeless debate: resolving TIM's noncircadian roles with possible clock functionAnthony L Gotter
Journal of Molecular Biology|July 24, 2003
Tipin, a novel timeless-interacting protein, is developmentally co-expressed with timeless and disrupts its self-associationAnthony L Gotter
Journal of Molecular Biology|December 5, 2006
Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factorsAnthony L Gotter, Christine Suppa, Beverly S Emanuel
Science (New York, N.Y.)|May 24, 2003
Illuminating the circadian clock in monarch butterfly migrationOren Froy, Anthony L Gotter, Amy L Casselman, et al.
Human Molecular Genetics|September 4, 2003
A novel sequence-based approach to localize translocation breakpoints identifies the molecular basis of a t(4;22)Manjunath A Nimmakayalu, Anthony L Gotter, Tamim H Shaikh, et al.
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Human Molecular Genetics|November 14, 2003
A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2Anthony L Gotter, Tamim H Shaikh, Marcia L Budarf, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Plos One|May 17, 2011
Timeless links replication termination to mitotic kinase activationJayaraju Dheekollu, Andreas Wiedmer, James Hayden, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Neuroreport|September 5, 2006
A Timeless debate: resolving TIM's noncircadian roles with possible clock functionAnthony L Gotter
Journal of Molecular Biology|July 24, 2003
Tipin, a novel timeless-interacting protein, is developmentally co-expressed with timeless and disrupts its self-associationAnthony L Gotter
Journal of Molecular Biology|December 5, 2006
Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factorsAnthony L Gotter, Christine Suppa, Beverly S Emanuel
Science (New York, N.Y.)|May 24, 2003
Illuminating the circadian clock in monarch butterfly migrationOren Froy, Anthony L Gotter, Amy L Casselman, et al.
Human Molecular Genetics|September 4, 2003
A novel sequence-based approach to localize translocation breakpoints identifies the molecular basis of a t(4;22)Manjunath A Nimmakayalu, Anthony L Gotter, Tamim H Shaikh, et al.
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Human Molecular Genetics|November 14, 2003
A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2Anthony L Gotter, Tamim H Shaikh, Marcia L Budarf, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Plos One|May 17, 2011
Timeless links replication termination to mitotic kinase activationJayaraju Dheekollu, Andreas Wiedmer, James Hayden, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Pageof 5